Header cover image

Canadian (TSX) Clinical Research and Equipment Industry Analysis

UpdatedMay 26, 2022
DataAggregated Company Financials
Companies5
  • 7D1.9%
  • 3M-6.0%
  • 1Y-30.1%
  • YTD-29.8%

In the last week, the Clinical Research and Equipment industry is up 1.9%, with ImmunoPrecise Antibodies up 10%. During this same period, the Telescope Innovations underperformed, falling 56%. In the past year, the industry is down 30%. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Canadian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 28 May 2022CA$196.7mCA$21.5m-CA$26,635,227.0015.9x
Mon, 25 Apr 2022CA$237.3mCA$21.6m-CA$23,635,914.0025.9x
Wed, 23 Mar 2022CA$168.1mCA$21.6m-CA$23,635,914.0025.9x
Fri, 18 Feb 2022CA$194.1mCA$21.3m-CA$21,103,914.0027.3x
Sun, 16 Jan 2022CA$251.4mCA$20.9m-CA$20,076,847.0030x
Tue, 14 Dec 2021CA$239.9mCA$21.0m-CA$14,997,109.0025.9x
Thu, 11 Nov 2021CA$259.1mCA$21.0m-CA$14,997,109.0024.6x
Sat, 09 Oct 2021CA$249.3mCA$20.7m-CA$14,899,797.0025.2x
Mon, 06 Sep 2021CA$248.4mCA$20.7m-CA$11,409,216.0021.1x
Wed, 04 Aug 2021CA$243.2mCA$20.7m-CA$11,409,216.0019.1x
Sat, 08 May 2021CA$239.1mCA$19.3m-CA$7,096,150.0027.1x
Tue, 09 Feb 2021CA$373.7mCA$18.4m-CA$3,146,070.0068.4x
Mon, 02 Nov 2020CA$180.4mCA$17.7m-CA$2,528,358.00134.5x
Thu, 06 Aug 2020CA$113.0mCA$16.0m-CA$3,506,338.00n/a
Sun, 10 May 2020CA$53.3mCA$14.1m-CA$4,947,000.00n/a
Sat, 01 Feb 2020CA$70.5mCA$13.6m-CA$24,476,059.00n/a
Tue, 05 Nov 2019CA$84.9mCA$13.1m-CA$22,948,478.00145x
Fri, 09 Aug 2019CA$95.7mCA$11.7m-CA$22,704,312.00n/a
Median PE Ratio

n/a


Total Market Cap: CA$110.0mTotal Earnings: -CA$21,855,614.00Total Revenue: CA$11.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Clinical Research and Equipment Industry Median PE3Y Average 37.4x202020212022
Current Industry PEThere is only one profitable company in this industry, so there is insufficient data to make an industry-wide assessment of PE.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 22% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Canadian Clinical Research and Equipment compare with similar industries?

CA Market1.68%
Healthcare0.16%
Life Sciences1.89%
Clinical Research and Equipment1.89%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IPA ImmunoPrecise AntibodiesCA$6.8013.3%
+CA$18.8m
-28.6%PS8.4x
DOSE Rapid Dose TherapeuticsCA$0.215.0%
+CA$1.0m
0%PS21.1x
LEXT Lexston Life SciencesCA$0.09830.0%
+CA$263.7k
n/an/a
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News